| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.48 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.003 |